BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 19772789)

  • 1. Examination of in vivo gelatinolytic activity in rheumatoid arthritis synovial tissue using newly developed in situ zymography and image analyzer.
    Yoshida W; Uzuki M; Nishida J; Shimamura T; Sawai T
    Clin Exp Rheumatol; 2009; 27(4):587-93. PubMed ID: 19772789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active synovial matrix metalloproteinase-2 is associated with radiographic erosions in patients with early synovitis.
    Goldbach-Mansky R; Lee JM; Hoxworth JM; Smith D; Duray P; Schumacher RH; Yarboro CH; Klippel J; Kleiner D; El-Gabalawy HS
    Arthritis Res; 2000; 2(2):145-53. PubMed ID: 11062605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis.
    Ahrens D; Koch AE; Pope RM; Stein-Picarella M; Niedbala MJ
    Arthritis Rheum; 1996 Sep; 39(9):1576-87. PubMed ID: 8814070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gelatinase expression and activity in the synovium and skin of patients with erosive psoriatic arthritis.
    Hitchon CA; Danning CL; Illei GG; El-Gabalawy HS; Boumpas DT
    J Rheumatol; 2002 Jan; 29(1):107-17. PubMed ID: 11824946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced chemokine and matrix metalloproteinase expression in patients with rheumatoid arthritis achieving remission.
    Katrib A; Smith MD; Ahern MJ; Slavotinek J; Stafford L; Cuello C; Bertouch JV; McNeil HP; Youssef PP
    J Rheumatol; 2003 Jan; 30(1):10-21. PubMed ID: 12508384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased in situ gelatinolytic activity in renal cell tumor tissues correlates with tumor size, grade and vessel invasion.
    Kamiya N; Kishimoto T; Suzuki H; Sekita N; Nagai Y; Oosumi N; Kito H; Tochigi N; Shinbo M; Nemori R; Ichikawa T; Igarashi T; Ito H; Ishikura H
    Int J Cancer; 2003 Sep; 106(4):480-485. PubMed ID: 12845641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zymographic analysis using gelatin-coated film of the effect of etanercept on the extracellular matrix-degrading activity in synovial fluids of rheumatoid arthritis patients.
    Kamataki A; Ishida M; Komagamine M; Yoshida M; Ando T; Sawai T
    Int J Rheum Dis; 2016 Apr; 19(4):385-91. PubMed ID: 24618272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of matrix metalloproteinase-9 (gelatinase B) in gouty arthritis and stimulation of MMP-9 by urate crystals in macrophages.
    Hsieh MS; Ho HC; Chou DT; Pan S; Liang YC; Hsieh TY; Lan JL; Tsai SH
    J Cell Biochem; 2003 Jul; 89(4):791-9. PubMed ID: 12858344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous MMP-9 and not MMP-2 promotes rheumatoid synovial fibroblast survival, inflammation and cartilage degradation.
    Xue M; McKelvey K; Shen K; Minhas N; March L; Park SY; Jackson CJ
    Rheumatology (Oxford); 2014 Dec; 53(12):2270-9. PubMed ID: 24982240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MMP-2, MMP-9, TIMP-1 and TIMP-2 levels in patients with rheumatoid arthritis and psoriatic arthritis.
    Giannelli G; Erriquez R; Iannone F; Marinosci F; Lapadula G; Antonaci S
    Clin Exp Rheumatol; 2004; 22(3):335-8. PubMed ID: 15144129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of human type IIa secretory phospholipase A2 antigen in arthritic synovium.
    Jamal OS; Conaghan PG; Cunningham AM; Brooks PM; Munro VF; Scott KF
    Ann Rheum Dis; 1998 Sep; 57(9):550-8. PubMed ID: 9849315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In situ gelatinolytic activity correlates with tumor progression and prognosis in patients with bladder cancer.
    Kawamura K; Kamiya N; Suyama T; Shimbo M; Oosumi N; Suzuki H; Ueda T; Tobe T; Igarashi T; Ito H; Ishikura H
    J Urol; 2004 Oct; 172(4 Pt 1):1480-4. PubMed ID: 15371875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in rheumatoid synovium.
    Yamanaka H; Makino K; Takizawa M; Nakamura H; Fujimoto N; Moriya H; Nemori R; Sato H; Seiki M; Okada Y
    Lab Invest; 2000 May; 80(5):677-87. PubMed ID: 10830778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and localisation of the new metalloproteinase inhibitor RECK (reversion inducing cysteine-rich protein with Kazal motifs) in inflamed synovial membranes of patients with rheumatoid arthritis.
    van Lent PL; Span PN; Sloetjes AW; Radstake TR; van Lieshout AW; Heuvel JJ; Sweep CG; van den Berg WB
    Ann Rheum Dis; 2005 Mar; 64(3):368-74. PubMed ID: 15485996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of gelatinolytic activity in tumor tissues by synthetic matrix metalloproteinase inhibitor: application of film in situ zymography.
    Ikeda M; Maekawa R; Tanaka H; Matsumoto M; Takeda Y; Tamura Y; Nemori R; Yoshioka T
    Clin Cancer Res; 2000 Aug; 6(8):3290-6. PubMed ID: 10955815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased level of heme oxygenase-1 in rheumatoid arthritis synovial fluid.
    Kitamura A; Nishida K; Komiyama T; Doi H; Kadota Y; Yoshida A; Ozaki T
    Mod Rheumatol; 2011 Apr; 21(2):150-7. PubMed ID: 21113640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
    Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K
    J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression levels of matrix metalloproteinase (MMP)-9 and its specific inhibitor TIMP-1, in septic and aseptic arthritis of the knee.
    Fotopoulos VC; Tzinia A; Tzurbakis M; Kalfakakou V; Levidiotou-Stefanou S; Georgoulis A
    Knee Surg Sports Traumatol Arthrosc; 2012 Jun; 20(6):1159-67. PubMed ID: 21946941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute-phase serum amyloid A regulates tumor necrosis factor α and matrix turnover and predicts disease progression in patients with inflammatory arthritis before and after biologic therapy.
    Connolly M; Mullan RH; McCormick J; Matthews C; Sullivan O; Kennedy A; FitzGerald O; Poole AR; Bresnihan B; Veale DJ; Fearon U
    Arthritis Rheum; 2012 Apr; 64(4):1035-45. PubMed ID: 22076945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolactin locally produced by synovium infiltrating T lymphocytes induces excessive synovial cell functions in patients with rheumatoid arthritis.
    Nagafuchi H; Suzuki N; Kaneko A; Asai T; Sakane T
    J Rheumatol; 1999 Sep; 26(9):1890-900. PubMed ID: 10493666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.